Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -15.67x is 21% above its 2-year average of -19.85x, near the high end of its 2-year range (-65.49x–-1.58x).
10.17% above its 12-month average of -17.44x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -18.78x.
INTEREST COVERAGE RATIO
-15.67x
INTEREST COVERAGE RATIO AVG TTM
-17.44x
INTEREST COVERAGE RATIO AVG 3Y
-19.85x
INTEREST COVERAGE RATIO AVG 5Y
-19.85x
INTEREST COVERAGE RATIO AVG 10Y
-14.25x
INTEREST COVERAGE RATIO AVG 15Y
-10.84x
INTEREST COVERAGE RATIO AVG 20Y
-11.91x
CURRENT VS TTM AVG
+10.17%
CURRENT VS 3Y AVG
+21.06%
CURRENT VS 5Y AVG
+21.06%
CURRENT VS 10Y AVG
-9.94%
CURRENT VS 15Y AVG
-44.50%
CURRENT VS 20Y AVG
-31.61%
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 323 covered companies
CURRENT VS SECTOR MEDIAN
-273.10%
vs the sector median at left
Dyadic International, Inc.
Market Cap
$16.54M
Interest Coverage Ratio
-15.67x
TTM Avg
-17.44x
3Y Avg
-19.85x
5Y Avg
-19.85x
Market Cap
$16.58M
Interest Coverage Ratio
-111.88x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.91M
Interest Coverage Ratio
-68.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.30M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.20M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.20M
Interest Coverage Ratio
-1.98x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.77M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.28M
Interest Coverage Ratio
-143.87x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyadic International, Inc. (DYAI) | $16.54M | -15.67x | -17.44x | -19.85x | -19.85x |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | -111.88x | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $16.22M | N/A | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | -68.14x | N/A | N/A | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | N/A | N/A | N/A | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.20M | N/A | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.20M | -1.98x | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | N/A | N/A | N/A | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.28M | -143.87x | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -6.31x | 0.97x | 0.97x | 0.97x |
Interest Coverage
-15.7x
Debt/Equity
N/A
Current Ratio
1.65
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -18.78x |
| 2026-03-31 | -17.51x |
| 2025-12-31 | -13.33x |
| 2025-09-30 | -22.41x |
| 2025-06-30 | -15.19x |
| 2025-03-31 | -17.63x |
| 2024-12-31 | -12.12x |
| 2024-09-30 | -1.58x |
| 2024-06-30 | -14.48x |
| 2024-03-31 | -65.49x |
| 2018-12-31 | -7.15x |
| 2017-12-31 | -9.22x |
| 2017-09-30 | -11.87x |
| 2017-06-30 | -11.35x |
| 2016-06-30 | -8514.87x |
| 2016-03-31 | -1376.88x |
| 2014-03-31 | -8.42x |
| 2013-12-31 | -2.43x |
| 2013-09-30 | -7.27x |
| 2013-06-30 | 20.76x |
| 2013-03-31 | -7.61x |
| 2012-09-30 | -4.19x |
| 2012-06-30 | 24.24x |
| 2012-03-31 | -3.49x |
| 2006-12-31 | -43.58x |
| 2006-09-30 | -33.52x |
| 2006-06-30 | -10.48x |
| 2006-03-31 | -12.60x |
| 2005-12-31 | -13.60x |
| 2005-09-30 | -158.09x |
| 2005-06-30 | -12.65x |
| 2005-03-31 | -16.36x |
| 2004-12-31 | -8.75x |
| 2004-06-30 | -65.30x |
